TOVX - חוב לטווח קצר להון Theriva Biologics

Market price action on GURU.Markets demonstrates the 0.04 metric, while Theriva Biologics, Inc. (TOVX) conducts independent clinical trials, excluding mergers. The business relies on the unique VCN-01 virus, which destroys the protective layer of pancreatic tumors. Additionally, Theriva Biologics, Inc. (TOVX) is developing partnerships with medical centers to jointly create innovative therapy methods for combating severe forms of colorectal cancer.

This indicator assesses the share of short-term liabilities within the equity structure to determine liquidity risk and the degree of dependence on borrowed funds; by analyzing the trend of short-term loans relative to equity, an investor can gauge debt management efficiency, which is critical for Theriva Biologics, Inc. (TOVX) when financing external clinical trials via outsourcing without creating redundant production capacities.